Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » All of Us Program Working on IDE Submission to FDA, Weighing Long-Read Sequencing Techs

All of Us Program Working on IDE Submission to FDA, Weighing Long-Read Sequencing Techs

Oct 24, 2019
|
Julia Karow
Premium

This article has been updated to clarify that the All of Us program still intends to use genotyping arrays on all participants to generate data for research and for returning non-health-related results.

NEW YORK – The National Institutes of Health's All of Us research program is working on an investigational device exemption (IDE) submission to the US Food and Drug Administration to return results to participants next year and is adjusting the mix of genomic technologies to generate data for its study cohort.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Robots for the Lab

Researchers have developed a robotic lab assistant, the Verge reports.

Ruling Awaited

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

To Find Where It Came From

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

Science Presents Atlas of Aberrant Cells in Lung Condition, More

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
16
Featured Webinar

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

Sponsored by
NanoString

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response. 

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
29
Featured Webinar

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

Sponsored by
Illumina

“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell.

What's Popular?

In Sequencing

  1. Dual-Reader Nanopore Promises Improved Homopolymer Sequencing Accuracy

    Premium

  2. Prediabetes, Type 2 Diabetes Come With Altered Gut Microbiomes

  3. Paragon Genomics Betting Updated SARS-CoV-2 NGS Kit Will Enable High-Throughput Research, Testing

    Premium

  4. Aneuploidy Common in Early-Stage Human Embryos, Single-Cell RNA-Seq Study Reveals

  5. Study Spells Out Immune, Genomic, Epigenomic Interactions in Hematological Malignancies

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.